Global panic attack treatment market projected to reach USD 8.66 billion by 2032.

From GlobeNewswire: 2025-05-23 07:00:00

The global panic attack treatment market is projected to reach USD 2.92 billion in 2025, growing to USD 8.66 billion by 2032 at a CAGR of 16.8%. North America and Europe lead the market, with Asia Pacific expected to show rapid growth due to increasing awareness and prevalence of anxiety disorders.

One of the key drivers of market growth is the rising prevalence of panic disorder and panic attacks globally. The lifetime prevalence of panic attacks is 13.2%, leading to a surge in demand for panic attack treatments and therapies.

However, the market growth may be limited by side effects of panic attack treatments such as fatigue, weight gain, and dependency on drugs like benzodiazepines. Adverse effects can lead to discontinuation of treatment, affecting overall market demand.

Growing awareness of mental health issues and efforts to destigmatize them are creating growth opportunities for panic attack drug manufacturers. Initiatives by governments and NGOs to educate and reduce stigma are fostering a conducive environment for market expansion.

Advancements in medical research are leading to the development of novel pharmacological therapies with better safety profiles. Integration of behavioral interventions like Cognitive Behavioral Therapy (CBT) and telehealth platforms are improving accessibility to mental health services, positively impacting market growth. Key companies like Hoffmann-La Roche Ltd. and Johnson & Johnson are leading the global panic attack treatment market. In January 2025, Johnson & Johnson’s SPRAVATO was approved by the U.S. FDA as the first monotherapy for treatment-resistant depression. Mind Medicine Inc. also began its Phase 3 study for generalized anxiety disorder treatment.

The panic attack treatment market is segmented by drug class, route of administration, distribution channel, and region. Antidepressants and anti-anxiety drugs are key classes, with various administration routes like oral and intravenous. Distribution channels include hospital, retail, and online pharmacies, with markets in North America, Europe, and Asia.

Coherent Market Insights offers in-depth analysis of market trends and consumer behaviors. With over a decade of experience, they provide valuable research and analytics to empower businesses for growth. They have a team of 450+ experts across 26+ industries in 32+ countries. Stay updated by following them on LinkedIn, Facebook, and Twitter.



Read more at GlobeNewswire: Panic Attack Treatment Market to Reach USD 8.66 Billion,